At dosages of 45, 90, and 180 mg/kg ETS significantly attenuated the pathological changes associated with NAFLD induced by HFD, namely, hepatomegaly, elevated liver lipids and lipid peroxides, serum ALT levels, free fatty acids, and macro and micro hepatic steatosis. The gene discussed is GPT; the disease is Hepatic steatosis.